FINWIRES · TerminalLIVE
FINWIRES

Economy Expanded 0.4% In Q1 When February Rise, Flat Advance Read For March Are Taken Into Account, says Statistics Canada

作者

-- Canadian real gross domestic product (GDP) was up 0.2% month over month in February, with goods-producing industries driving the growth for the second consecutive month, said the country's statistical agency on Thursday.

February's GDP growth was perfectly in line with a consensus figure provided by MUFG.

Advance information indicates that real GDP was "essentially unchanged" in March, writes Statistics Canada in a statement. Increases in wholesale trade and transportation and warehousing were offset by decreases in retail trade and mining, quarrying, and oil and natural gas extraction.

With this advance estimate for March, information on real GDP by industry suggests the economy expanded 0.4% in Q1 2026, stated StatsCan.

Goods-producing industries grew 0.4% month over month in February, driven by expansions in manufacturing and mining, quarrying, and oil and gas extraction, added the Ottawa-based agency. Services-producing industries edged up 0.1%, as rebounds in transportation and warehousing and wholesale trade were largely offset by contractions in the public sector.

For Canada, GDP and Income and Expenditure Accounts measure the production of goods and services in the Canadian economy as well as the incomes arising from this production and expenditure on the production. GDP represents the unduplicated value of goods and services produced during the reference period and are available for domestic consumption, investment or export.

相關文章

Sectors

產業動態:消費者

週四下午,消費性股票走高,道富消費必需品精選行業SPDR ETF (XLP)上漲1.4%,道富非必需消費品精選行業SPDR ETF (XLY)上漲0.4%。 公司方面,蘭姆韋斯頓(LW)股價上漲1.6%,此前股東Starboard Value週四致信董事會,表示公司應召開投資者日活動,並將盈利預期調整至正常水平。

$LW
Research

研究快訊:CFRA維持對Firstenergy Corp.股票的買進評等。

獨立研究機構CFRA向提供了以下研究報告。 CFRA分析師的觀點摘要如下:我們將12個月目標股價下調1美元至55美元,本益比為20倍,基於未來12個月每股收益預期2.75美元,高於五年平均15.6倍。我們將2026年每股收益預期下修0.02美元至2.72美元,並將2027年每股收益預期下修0.01美元至2.93美元。第一季核心每股收益年增7.5%,打破了先前連續三個季度下滑的局面,我們預計在整個預測期內,成長動能將持續。 我們觀察到資料中心需求呈現正面趨勢,長期合約需求(4.3 GW)自 2026 年 2 月(4.1 GW)以來成長了 4%,自 2025 年 2 月(2.9 GW)以來成長了 47%;同時,在建專案需求(14.9 GW)自 2026 年 2012 年 125%, 2 月(6.1 GW)以來增長了一倍以上。自 2022 年以來,FE 已將基礎維運成本降低了 2 億美元以上(15%),預計 2026 年第一季將年比進一步下降約 5%,同時可靠性指標也得到提升。我們認為,FE 的成本控制、服務品質的提升以及具有競爭力的價格定位,將轉化為更有利的費率調整結果、更低的拒付風險以及更高的潛在淨資產收益率 (ROE)。

$FE
Australia

市場動態:FDA專家小組投票反對阿斯特捷利康乳癌藥物的益處

根據彭博社週四報道,美國食品藥物管理局(FDA)腫瘤藥物諮詢委員會否決了阿斯特捷利康(AZN)用於治療乳癌的候選藥物卡美司群(Camizestrant)的療效。 彭博社稱,六名委員會成員投票反對該藥物,因為他們對試驗設計及其在臨床應用中的潛在影響存在分歧。 根據一份簡報文件,該藥物試驗達到了無惡化存活期(PFS)的主要終點以及無惡化存活期2(PFS2)終點,但FDA認為PFS2不適合作為監管決策的終點。 (市場動態新聞來自與全球市場專業人士的對話。這些資訊據信來自可靠來源,但可能包含傳聞和推測。準確性無法保證。)Price: $189.60, Change: $+4.40, Percent Change: +2.37%

$AZN